Business
908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., April 21, 2026--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications.
About this update from Repligen Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4743,"height":1356,"url":"https://media.zenfs.com/en/business-wire.com/d9fe43f0d3d248331fb78fc46bd47be4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/sQZk98zz3G22SafFnrXmMw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI3NA--/https://media.zenfs.com/en/business-wire.com/d9fe43f0d3d248331fb78fc46bd47be4","width":960,"height":274},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/85ZxAqoguVXX5x7BgSHzkw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02ODY-/https://media.zenfs.com/en/business-wire.com/d9fe43f0d3d248331fb78fc46bd47be4","width":1200,"height":343}},"lazy":false},{"type":"text","content":"BURLINGTON, Mass., April 21, 2026--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications.","length":512,"tagName":"p"},{"type":"text","content":"Mr. Otitoju brings over 25 years of proven executive leadership in strategy, business development, and P&L management across the medical technology, life sciences, and industrial sectors. Most recently, he served as Senior Vice President of Strategy & Business Development at Repligen Corporation, where he led the company's global corporate strategy and executed more than 15 M&A transactions and strategic partnerships over six years, supporting the company's approximately 20% compound annual growth rate to over $700 million of revenues.","length":561,"tagName":"p"},{"type":"text","content":""We are thrilled to welcome Kola to 908 Devices as we build on the momentum of our 2.0 transformation and enter our next phase of growth," said Kevin J. Knopp, CEO and Co-founder. "His exceptional track record in driving both organic and inorganic growth makes him the ideal leader to accelerate our strategic initiatives and deliver long-term shareholder value. M&A and industry partnerships have already been successful and integral to our...